GSK Pharma shares surge 14% after Q1 results
The stock rose sharply by 13.91 percent to end at Rs 3,150.90 on BSE.
Jul 24, 2018, 17:40 PM ISTGlaxoSmithKline beats profit forecasts despite Advair hit, lower margins
A further slide in sales of lung drug Advair and lower profit margins following a business overhaul hit GlaxoSmithKline in the second quarter, although core earnings per share fell by a less than expected 9 percent.
Jul 29, 2015, 18:03 PM IST